Dark Pharma · DP-018
THEY THREATENED TO WITHDRAW THE DRUGS. THERE WERE NO ALTERNATIVES. WE PAID THEM ANYWAY.
On March 14th, 2017, a letter arrived demanding a 4,000% price increase for crucial cancer treatments. With no alternatives, the agency faced an aggressive ultimatum: pay up or lose access to essential therapies.
Case Assets
The Case Debrief is free to view. Full Case Study, Teaching Notes, Slide Deck, Discussion Guide, and Assessment are available with a Premium subscription.
Brief the Board
PREMIUM
🔒 Unlock
Learn the Case
FREE — included
Study the Case
PREMIUM
🔒 Unlock
Teach the Case
PREMIUM
🔒 Unlock
Present the Case
PREMIUM
🔒 Unlock
Run a Team Discussion
PREMIUM
🔒 Unlock
Test Your Judgement
PREMIUM
🔒 Unlock
Watch the Full Episode
The complete cinematic audio documentary — Dark Pharma
Unlock the Full Case Library
Get every Case Study, Slide Deck, Teaching Notes, Discussion Guide, and Assessment — across a growing library of business cases.
View Pricing →Related Cases
Cases that share a governance or behavioural model with this one.
Machine Room
MX-021
He Read The Draft At Midnight. He Called Legal By Morning. They Publis...
Shared: Stakeholder Engagement Framework, Risk Assessment Protocol
The Model Room
MR-041
SHE FILED THE DIVERSITY REPORT IN SEPTEMBER. IT MEASURED A 40 PERCENT ...
Shared: Stakeholder Engagement Framework
Dark Capital
DC-055
THE BUYER PAID SEVENTEEN MILLION. THE PENSION FUND OWED THREE HUNDRED....
Shared: Stakeholder Engagement Framework
Empire Builders
EB-040
HE DECLINED THE OFFER AT NINE HUNDRED MILLION. THE BOARD NEVER SAW THE...
Shared: Risk Assessment Protocol